JP7743239B2 - 乳幼児アトピー性皮膚炎の検出方法 - Google Patents

乳幼児アトピー性皮膚炎の検出方法

Info

Publication number
JP7743239B2
JP7743239B2 JP2021151505A JP2021151505A JP7743239B2 JP 7743239 B2 JP7743239 B2 JP 7743239B2 JP 2021151505 A JP2021151505 A JP 2021151505A JP 2021151505 A JP2021151505 A JP 2021151505A JP 7743239 B2 JP7743239 B2 JP 7743239B2
Authority
JP
Japan
Prior art keywords
atopic dermatitis
gene
ssl
tarc
rna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021151505A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022049694A (ja
JP2022049694A5 (enExample
Inventor
恭子 志摩
裕也 上原
高良 井上
直人 高田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Publication of JP2022049694A publication Critical patent/JP2022049694A/ja
Publication of JP2022049694A5 publication Critical patent/JP2022049694A5/ja
Application granted granted Critical
Publication of JP7743239B2 publication Critical patent/JP7743239B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/521—Chemokines
    • G01N2333/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1or LDCF-2
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/20—Dermatological disorders
    • G01N2800/202—Dermatitis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2021151505A 2020-09-16 2021-09-16 乳幼児アトピー性皮膚炎の検出方法 Active JP7743239B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020155444 2020-09-16
JP2020155444 2020-09-16

Publications (3)

Publication Number Publication Date
JP2022049694A JP2022049694A (ja) 2022-03-29
JP2022049694A5 JP2022049694A5 (enExample) 2025-02-18
JP7743239B2 true JP7743239B2 (ja) 2025-09-24

Family

ID=80776710

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021151505A Active JP7743239B2 (ja) 2020-09-16 2021-09-16 乳幼児アトピー性皮膚炎の検出方法

Country Status (5)

Country Link
US (1) US20240011093A1 (enExample)
EP (1) EP4215622A4 (enExample)
JP (1) JP7743239B2 (enExample)
CN (1) CN116194595A (enExample)
WO (1) WO2022059745A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115279901A (zh) * 2020-03-11 2022-11-01 花王株式会社 来自皮肤表面脂质的rna的制备方法
WO2024232368A1 (ja) * 2023-05-08 2024-11-14 花王株式会社 アトピー性皮膚炎の重症度の検出方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019217478A1 (en) 2018-05-09 2019-11-14 Dermtech, Inc. Novel gene classifiers and uses thereof in autoimmune diseases
JP2020074769A (ja) 2018-11-01 2020-05-21 花王株式会社 被験体の皮膚細胞に由来する核酸の調製方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6835479B2 (ja) * 2016-04-28 2021-02-24 株式会社 資生堂 アトピー性皮膚炎の皮膚局所の重症度及び治療効果の指標
RU2743813C2 (ru) * 2016-06-16 2021-02-26 Као Корпорейшн Способ оценки состояния кожи младенца
EP3719138B1 (en) 2016-07-08 2022-09-21 Kao Corporation Method for preparing nucleic acid sample
US11376261B2 (en) * 2017-12-18 2022-07-05 University Of Cincinnati Methods for diagnosing and managing treatment of atopic dermatitis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019217478A1 (en) 2018-05-09 2019-11-14 Dermtech, Inc. Novel gene classifiers and uses thereof in autoimmune diseases
JP2020074769A (ja) 2018-11-01 2020-05-21 花王株式会社 被験体の皮膚細胞に由来する核酸の調製方法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
GUTTMAN-YASSKY, E. et al.，Use of Tape Strips to Detect Immune and Barrier Abnormalities in the Skin of Children With Early-Ons，JAMA Dermatology，2019年，Vol.155, No.12，P.1358-1370，doi:10.1001/jamadermatol.2019.2983
PAVEL, A. B. et al.，Tape strips from early-onset pediatric atopic dermatitis highlight disease abnormalities in nonlesio，Allergy，2020年07月08日，Vol.76, No.1，P.314-325，doi：10.1111/all.14490

Also Published As

Publication number Publication date
JP2022049694A (ja) 2022-03-29
US20240011093A1 (en) 2024-01-11
CN116194595A (zh) 2023-05-30
EP4215622A1 (en) 2023-07-26
WO2022059745A1 (ja) 2022-03-24
EP4215622A4 (en) 2024-11-20

Similar Documents

Publication Publication Date Title
WO2021221138A1 (ja) アトピー性皮膚炎の検出方法
JP7743217B2 (ja) アトピー性皮膚炎の重症度の検出方法
EP4215622A1 (en) Method for detecting infantile atopic dermatitis
JP7762549B2 (ja) アトピー性皮膚炎の症度変化の検出方法
JP7743475B2 (ja) アトピー性皮膚炎の検出方法
JP7743289B2 (ja) アトピー性皮膚炎の症度の検出方法
JP7767500B2 (ja) アトピー性皮膚炎の重症度の検出方法
JP7743474B2 (ja) 乳幼児アトピー性皮膚炎の検出方法
WO2022220298A1 (ja) 乳幼児おむつ皮膚炎の症度の検出方法
US20210087634A1 (en) Determination of risk for development of cardiovascular disease by measuring urinary levels of podocin and nephrin messenger rna
JP7847450B2 (ja) アトピー性皮膚炎の症度悪化の検出方法
JP7847451B2 (ja) アトピー性皮膚炎による皮膚痒みの症度悪化の検出方法
WO2022220299A1 (ja) 乳幼児顔湿疹の症度の検出方法
JP2023048811A (ja) 疲労の検出方法
JP2023073134A (ja) ホットフラッシュの検出方法
JP2023045067A (ja) 不眠の検出方法
JP2023073135A (ja) 更年期障害の重症度の検出方法

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240515

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250207

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250225

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250428

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250626

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250826

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250910

R150 Certificate of patent or registration of utility model

Ref document number: 7743239

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150